Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study

BACKGROUND: The RTS,S/AS01 vaccine against Plasmodium falciparum malaria infection completed phase III trials in 2014 and demonstrated efficacy against clinical malaria of approximately 36% over 4 years for a 4-dose schedule in children aged 5–17 months. Pilot vaccine implementation has recently beg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogan, Alexandra B., Winskill, Peter, Ghani, Azra C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703928/
https://www.ncbi.nlm.nih.gov/pubmed/33253211
http://dx.doi.org/10.1371/journal.pmed.1003377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703928/
https://www.ncbi.nlm.nih.gov/pubmed/33253211
http://dx.doi.org/10.1371/journal.pmed.1003377

Ejemplares similares